Concord Biotech informs about investor’s presentation

14 Feb 2025 Evaluate
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Concord Biotech has informed that it enclosed ‘INVESTOR’S PRESENTATION’ on Financial Results for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.


Concord Biotech Share Price

1404.05 1.00 (0.07%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×